Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo

Retrovirology

Volumn 9, Issue , 2012, Pages

  Jones, Philip H ^a   Mehta, Harshini V ^a   Maric, Martina ^a   Roller, Richard J ^a   Okeoma, Chioma M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

BST 2; In vivo; Interferon alpha; MMTV; SEM; TEM; Tetherin

Indexed keywords

ALPHA INTERFERON; BONE MARROW STROMAL CELL ANTIGEN 2; CELL ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; BST2 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; IN VIVO STUDY; LYMPH NODE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETROVIRUS INFECTION; RNA INTERFERENCE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS INHIBITION; VIRUS RELEASE; VIRUS REPLICATION; ANIMAL; C3H MOUSE; C57BL MOUSE; CELL LINE; GENE SILENCING; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; MOUSE MAMMARY TUMOR VIRUS;

ANIMALS; ANTIGENS, CD; CELL LINE; GENE SILENCING; MAMMARY TUMOR VIRUS, MOUSE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; RNA INTERFERENCE; VIRUS RELEASE;

EID: 84856154164     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-10     Document Type: Article

References (35)

1. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-30. 10.1038/nature06553, 18200009.
2. Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT. Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol 2010, 84:11374-84. 10.1128/JVI.01067-10, 2953199, 20702620.
3. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, Lee Y, McNatt M, Hatziioannou T, Bieniasz PD. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 2009, 83:1837-44. 10.1128/JVI.02211-08, 2643743, 19036818.
4. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci USA 2009, 106:2886-91. 10.1073/pnas.0811014106, 2650360, 19179289.
5. Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, Oldenburg J, Cannon PM. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol 2010, 84:7243-55. 10.1128/JVI.02636-09, 2898217, 20444895.
6. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511. 10.1016/j.cell.2009.08.039, 2844890, 19879838.
7. Habermann A, Krijnse-Locker J, Oberwinkler H, Eckhardt M, Homann S, Andrew A, Strebel K, Krausslich HG. CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol 2010, 84:4646-58. 10.1128/JVI.02421-09, 2863769, 20147389.
8. Hammonds J, Wang JJ, Yi H, Spearman P. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog 2010, 6:e1000749. 10.1371/journal.ppat.1000749, 2816691, 20140192.
9. Fitzpatrick K, Skasko M, Deerinck TJ, Crum J, Ellisman MH, Guatelli J. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog 2010, 6:e1000701. 10.1371/journal.ppat.1000701, 2832767, 20221443.
10. Le Tortorec A, Neil SJ. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 2009, 83:11966-78. 10.1128/JVI.01515-09, 2772693, 19740980.
11. Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol 2009, 83:4574-90. 10.1128/JVI.01800-08, 2668474, 19244337.
12. Goffinet C, Homann S, Ambiel I, Tibroni N, Rupp D, Keppler OT, Fackler OT. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J Virol 2010, 84:4089-94. 10.1128/JVI.01549-09, 2849503, 20147395.
13. Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, Guatelli JC, Cannon PM. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 2010, 7:51. 10.1186/1742-4690-7-51, 2890665, 20529266.
14. Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, Bieniasz P, Kellam P, Towers GJ, Neil SJ. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog 2010, 6:e1000843. 10.1371/journal.ppat.1000843, 2855335, 20419159.
15. Burzyn D, Rassa JC, Kim D, Nepomnaschy I, Ross SR, Piazzon I. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol 2004, 78:576-84. 10.1128/JVI.78.2.576-584.2004, 368791, 14694089.
16. Beutner U, Kraus E, Kitamura D, Rajewsky K, Huber BT. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med 1994, 179:1457-66. 10.1084/jem.179.5.1457, 2191484, 8163931.
17. Martin P, Ruiz SR, del Hoyo GM, Anjuere F, Vargas HH, Lopez-Bravo M, Ardavin C. Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 2002, 99:1282-8. 10.1182/blood.V99.4.1282, 11830477.
18. Courreges MC, Burzyn D, Nepomnaschy I, Piazzon I, Ross SR. Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J Virol 2007, 81:3769-77. 10.1128/JVI.02728-06, 1866091, 17267484.
19. Dzuris JL, Golovkina TV, Ross SR. Both T and B cells shed infectious mouse mammary tumor virus. J Virol 1997, 71:6044-8. 191862, 9223496.
20. Golovkina TV, Dudley JP, Ross SR. B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J Immunol 1998, 161:2375-82.
21. Okeoma CM, Huegel AL, Lingappa J, Feldman MD, Ross SR. APOBEC3 proteins made in mammary epithelial cells can be packaged into retroviruses and restrict transmission of milk-borne virions. Cell Host Microbe 2010, 8:534-43. 10.1016/j.chom.2010.11.003, 3023938, 21147467.
22. Yoo H, Park SH, Ye SK, Kim M. IFN-gamma-induced BST2 mediates monocyte adhesion to human endothelial cells. Cell Immunol 2011, 267:23-9. 10.1016/j.cellimm.2010.10.011, 21094940.
23. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009, 6:54-67. 10.1016/j.chom.2009.05.008, 2852097, 19501037.
24. Jolly C, Booth NJ, Neil SJ. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J Virol 2010, 84:12185-99. 10.1128/JVI.01447-10, 2976402, 20861257.
25. Serra-Moreno R, Jia B, Breed M, Alvarez X, Evans DT. Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV. Cell Host Microbe 2011, 9:46-57. 10.1016/j.chom.2010.12.005, 3023977, 21238946.
26. Indik S, Gunzburg WH, Salmons B, Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res 2005, 65:6651-9. 10.1158/0008-5472.CAN-04-2609, 16061645.
27. Gonda MA, Arthur LO, Zeve VH, Fine DL, Nagashima K. Surface localization of virus production on a glucocorticoid-stimulated oncornavirus-producing mouse mammary tumor cell line by scanning electron microscopy. Cancer Res 1976, 36:1084-93.
28. Bittner JJ. SOME POSSIBLE EFFECTS OF NURSING ON THE MAMMARY GLAND TUMOR INCIDENCE IN MICE. Science 1936, 84:162.
29. Shackleford GM, Varmus HE. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci USA 1988, 85:9655-9. 10.1073/pnas.85.24.9655, 282828, 2849114.
30. Miesfeld R, Rusconi S, Godowski PJ, Maler BA, Okret S, Wikstrom AC, Gustafsson JA, Yamamoto KR. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 1986, 46:389-99. 10.1016/0092-8674(86)90659-8, 3755378.
31. Zhang Y, Rassa JC, deObaldia ME, Albritton LM, Ross SR. Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein. J Virol 2003, 77:10468-78. 10.1128/JVI.77.19.10468-10478.2003, 228533, 12970432.
32. Okeoma CM, Lovsin N, Peterlin BM, Ross SR. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007, 445:927-30. 10.1038/nature05540, 17259974.
33. Okeoma CM, Shen M, Ross SR. A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice. J Virol 2008, 82:1314-22. 10.1128/JVI.01848-07, 2224452, 18003725.
34. Schliemann C, Roesli C, Kamada H, Borgia B, Fugmann T, Klapper W, Neri D. In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy. Blood 2010, 115:736-44. 10.1182/blood-2009-08-239004, 19903902.
35. Parks WP, Ransom JC, Young HA, Scolnick EM. Mammary tumor virus induction by glucocorticoids Characterization of specific transcriptional regulation. J Biol Chem 1975, 250:3330-6.